These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35715263)

  • 21. Identification of a pyroptosis-related lncRNA signature in the regulation of prognosis, metabolism signals and immune infiltration in lung adenocarcinoma.
    Zhou S; Cai Y; Xu Z; Peng B; Liang Q; Peng J; Yan Y
    Front Endocrinol (Lausanne); 2022; 13():964362. PubMed ID: 36034461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
    Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
    Front Genet; 2022; 13():838624. PubMed ID: 35928454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
    Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
    Front Immunol; 2022; 13():854785. PubMed ID: 35392086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Machine learning-based integration develops an immunogenic cell death-derived lncRNA signature for predicting prognosis and immunotherapy response in lung adenocarcinoma.
    Sun J; Guo H; Zhang S; Nie Y; Zhou S; Zeng Y; Sun Y
    Sci Rep; 2024 May; 14(1):11724. PubMed ID: 38778157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive analysis of competitive endogenous RNA associated with immune infiltration in lung adenocarcinoma.
    Chen W; Li W; Liu Z; Ma G; Deng Y; Li X; Wang Z; Zhou Q
    Sci Rep; 2021 May; 11(1):11056. PubMed ID: 34040139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated analysis of hypoxia-associated lncRNA signature to predict prognosis and immune microenvironment of lung adenocarcinoma patients.
    Shao J; Zhang B; Kuai L; Li Q
    Bioengineered; 2021 Dec; 12(1):6186-6200. PubMed ID: 34486476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-infiltrating macrophage associated lncRNA signature in cutaneous melanoma: implications for diagnosis, prognosis, and immunotherapy.
    Wan Q; Deng Y; Wei R; Ma K; Tang J; Deng YP
    Aging (Albany NY); 2024 Mar; 16(5):4518-4540. PubMed ID: 38475660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-cell RNA sequencing integrated with bulk RNA sequencing analysis identifies a tumor immune microenvironment-related lncRNA signature in lung adenocarcinoma.
    Ren Y; Wu R; Li C; Liu L; Li L; Weng S; Xu H; Xing Z; Zhang Y; Wang L; Liu Z; Han X
    BMC Biol; 2024 Mar; 22(1):69. PubMed ID: 38519942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
    Xiao R; Yang M; Tan Y; Ding R; Li D
    Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
    Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
    Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LARRPM restricts lung adenocarcinoma progression and M2 macrophage polarization through epigenetically regulating LINC00240 and CSF1.
    Li Y; Chen C; Liu HL; Zhang ZF; Wang CL
    Cell Mol Biol Lett; 2022 Oct; 27(1):91. PubMed ID: 36221069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploration of genes and tumor infiltrating lymphocytes in female lung adenocarcinoma microenvironment that predicted prognosis.
    Wang L; Wang H; Wei S; Zhang Z
    Medicine (Baltimore); 2021 Dec; 100(51):e28215. PubMed ID: 34941080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer-associated fibroblasts-derived lncRNA signature as a putative biomarker in breast cancer.
    Li Z; Yu J; Lv C; Luo Z
    Front Oncol; 2022; 12():1028664. PubMed ID: 36408190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.
    Chen G; Dong Z; Wu D; Chen Y
    J Cell Biochem; 2020 Nov; 121(11):4431-4439. PubMed ID: 32003059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
    Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L
    Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
    Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
    Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
    Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
    Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.